Resource Logo
AIDS Weekly Plus

Global Infectious Diseases Drug Pipeline Capsule - 2013 Report Gives Coverage on HIV, Malaria and Human Papillomavirus


2013 OCT 14 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- Research and Markets ( has announced the addition of the "Global Infectious Diseases Drug Pipeline Capsule - 2013" report to their offering (see also Research and Markets).

The latest report Global Infectious Diseases Drug Pipeline Capsule - 2013' provides up-to-date information on key research and development activities in the global infectious diseases drug market. It covers active pipeline molecules under development in various stages of clinical trials, preclinical research, and drug discovery for Hepatitis, HIV, Influenza, Small Pox, Malaria, Tuberculosis, Tetanus, Herpes Simplex, and Human Papillomavirus.

This report helps executives track their competitor's pipeline molecules. The information presented in this report can be used for identifying partners, evaluating business opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company, mechanism of action, stage (phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and drug discovery), and geography (North America, Europe, and Asia).

Keywords for this news article include: HIV/AIDS, RNA Viruses, Retroviridae, Tuberculosis, HIV Infections, Pre-Trial Research, Vertebrate Viruses, Infectious Diseases, Human Papillomavirus, Primate Lentiviruses, Research and Markets, Opportunistic Infections, Clinical Trials and Studies, Viral Sexually Transmitted Diseases.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2013, NewsRx LLC


Copyright © 2013 -AIDS Weekly Plus, Publisher. All rights reserved to Charles Henderson, Publisher. Permission to reproduce granted to AEGIS by Charles W. Henderson. Authorization to reproduce for personal use granted granted by C. W. Henderson, Publisher, provided that the fee of US$4.50 per copy, per page is paid directly to the Copyright Clearance Center, 27 Congress Street, Salem, Massachusetts 01970, USA. Published by Charles Henderson, Publisher. Editorial & Publishing Office: P.O. Box 5528, Atlanta, GA 30307-0528 / Telephone: (800) 633- 4931; Subscription Office: P.O. Box 830409, Birmingham, AL 35283-0409 / FAX:(205) 995-1588 Visit AIDS WEEKLY PLUS.

Information in this article was accurate in October 14, 2013. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.